Lillian Reich
About
In The Last Decade
Lillian Reich
18 papers receiving 668 citations
Peers
Comparison fields: 5 of 64
- Neurology 201
- Hematology 177
- Epidemiology 166
- Public Health, Environmental and Occupational Health 140
- Genetics 116
Countries citing papers authored by Lillian Reich
This map shows the geographic impact of Lillian Reich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lillian Reich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lillian Reich more than expected).
Fields of papers citing papers by Lillian Reich
This network shows the impact of papers produced by Lillian Reich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lillian Reich. The network helps show where Lillian Reich may publish in the future.
Co-authorship network of co-authors of Lillian Reich
This figure shows the co-authorship network connecting the top 25 collaborators of Lillian Reich. A scholar is included among the top collaborators of Lillian Reich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lillian Reich. Lillian Reich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 77 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 39 | |
| 7 | Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells. | 11 |
| 8 | 9 | |
| 9 | Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer. | 13 |
| 10 | Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial. | 13 |
| 11 | 59 | |
| 12 | 3 | |
| 13 | 9 | |
| 14 | 166 | |
| 15 | 162 | |
| 16 | Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol. | 35 |
| 17 | Prognostic factors and treatment of myelodysplastic syndromes. | 6 |
| 18 | 79 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.